High-resolution T2-weighted abdominal magnetic resonance imaging using respiratory triggering: Impact of butylscopolamine on image quality

Acta Radiologica

Volumn 49, Issue 4, 2008, Pages 376-382

  Wagner, M ^a   Klessen, C ^a   Rief, M ^a   Elgeti, T ^a   Taupitz, M ^a   Hamm, B ^a   Asbach, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Abdomen; Imaging sequences; Liver; MR imaging; Pancreas

Indexed keywords

AMINES; IMAGE QUALITY; PATIENT MONITORING; RADIOLOGY; SIGNAL ANALYSIS;

BUTYLSCOPOLAMINE; IMAGING SEQUENCES; MR IMAGING; PANCREAS;

MAGNETIC RESONANCE IMAGING;

CHOLINERGIC RECEPTOR BLOCKING AGENT; CONTRAST MEDIUM; DIAGNOSTIC AGENT; IRON; OXIDE; SCOPOLAMINE BUTYL BROMIDE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; BREATHING; CHI SQUARE DISTRIBUTION; COMPUTER ASSISTED DIAGNOSIS; DIGESTIVE SYSTEM DISEASE; FEMALE; HUMAN; IMAGE ENHANCEMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY;

BUTYLSCOPOLAMMONIUM BROMIDE; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; DIGESTIVE SYSTEM DISEASES; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, INTRAMUSCULAR; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PARASYMPATHOLYTICS; RESPIRATION; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 42649084712     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850801894806     Document Type: Article

References (25)

1. Keogan MT, Edelman RR. Technologie advances in abdominal MR imaging. Radiology 2001;220:310-20.
2. Barish MA, Jara H. Motion artifact control in body MR imaging. Magn Reson Imaging Clin N Am 1999;7:289-301.
3. Stark DD, Hendrick RE, Hahn PF, Ferruca JT Jr. Motion artifact reduction with fast spin-echo imaging. Radiology 1987;164:183-91.
4. Wood ML, Runge VM, Henkelman RM. Overcoming motion in abdominal MR imaging. Am J Roentgenol 1988;150:513-22.
5. Dosda R, Marti-Bonmati L, Ronchera-Oms CL, Molla E, Arana E. Effect of subcutaneous butylscopolamine administration in the reduction of peristaltic artifacts in 1.5-T MR fast abdominal examinations. Eur Radiol 2003;13:294-8.
6. Laniado M, Gronewaller E, Kopp AF, Kaminsky SF, Hamm B, Jacobsen TF, et al. The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles. Abdom Imaging 1997; 22:381-8.
7. Marti-Bonmati L, Graells M, Ronchera-Oms CL. Reduction of peristaltic artifacts on magnetic resonance imaging of the abdomen: a comparative evaluation of three drugs. Abdom Imaging 1996;21:309-13.
8. Klessen C, Asbach P, Kroencke TJ, Fischer T, Warmuth C, Stemmer A, et al. Magnetic resonance imaging of the upper abdomen using a free-breathing T2-weighted turbo spin echo sequence with navigator triggered prospective acquisition correction. J Magn Reson Imaging 2005;21:576-82.
9. Kaufman L, Kramer DM, Crooks LE, Ortendahl DA. Measuring signal-to-noise ratios in MR imaging. Radiology 1989;173:265-7.
10. Tang Y, Yamashita Y, Takahashi M. Ultrafast T2-weighted imaging of the abdomen and pelvis: use of single shot fast spin-echo imaging. J Magn Reson Imaging 1998;8:384-90.
11. Low RN, Alzate GD, Shimakawa A. Motion suppression in MR imaging of the liver: comparison of respiratory-triggered and nontriggered fast spin-echo sequences. Am J Roentgenol 1997;168:225-31.
12. Kanematsu M, Hoshi H, Itoh K, Murakami T, Hori M, Kondo H, et al. Focal hepatic lesion detection: comparison of four fat-suppressed T2-weighted MR imaging pulse sequences. Radiology 1999;211:363-71.
13. Lee SS, Byun JH, Hong HS, Park SH, Won HJ, Shin YM, et al, Image quality and focal lesion detection on T2-weighted MR imaging of the liver: comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques. J Magn Reson Imaging 2007;26:323-30.
14. Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Kreft B, et al. Improving the detectability of focal liver lesions on T2-weighted MR images: ultrafast breathhold or respiratory-triggered thin-section MRI? J Magn Reson Imaging 2001;14:128-33.
15. Hanninen EL, Ricke J, Amthauer H, Rottgen R, Bohmig M, Langrehr J, et al. Magnetic resonance cholangiopancreatography: image quality, ductal morphology, and value of additional T2- and T1-weighted sequences for the assessment of suspected pancreatic cancer. Acta Radiol 2005;46:117-25.
16. Brown JJ, Duncan JR, Heiken JP, Balfe DM, Corr AP, Mirowitz SA, et al. Perfiuoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 1991;181:455-60.
17. Kaminsky S, Laniado M, Gogoli M, Kornmesser W, Clauss W, Langer M, et al. Gadopentetate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 1991;178:503-8.
18. Marti-Bonmati L, Dosda R, Ronchera-Oms CL, Casillas C. Dose effect of dicyclomine on the reduction of peristaltic artifacts on MRI of the abdomen. Abdom Imaging 1999;24:336-9.
19. Weinreb JC, Maravilla KR, Redman HC, Nunnally R. Improved MR imaging of the upper abdomen with glucagon and gas. J Comput Assist Tomogr 1984;8:835-8.
20. Dromain C, de Baere T, Baudin E, Galline J, Ducreux M, Boige V, et al. MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. Am J Roentgenol 2003;180:121-8.
21. Zech CJ, Herrmann KA, Huber A, Dietrich O, Stemmer A, Herzog P, et al. High-resolution MR-imaging of the liver with T2-weighted sequences using integrated parallel imaging: comparison of prospective motion correction and respiratory triggering. J Magn Reson Imaging 2004;20:443-50.
22. Guignard JP, Herxheimer A, Greenwood RM. Effects of hyoscine butylbromide on gut motility. Clin Pharmacol Ther 1968;9:745-8.
23. Ajaj W, Ruhm SG, Papanikolaou N, Lauenstein TC, Gerken G, Goyen M. Dark lumen MR colonography: can high spatial resolution VIBE imaging improve the detection of colorectal masses? Rofo 2006;178:1073-8.
24. Froehlich JM, Patak MA, von Weymarn C, Juli CF, Zollikofer CL, Wentz KU. Small bowel motility assessment with magnetic resonance imaging. J Magn Reson Imaging 2005;21:370-5.
25. Fink AM, Aylward GW. Buscopan and glaucoma: a survey of current practice. Clin Radiol 1995;50:160-4.